Clear Search sequence regions

  • cell (1)
  • cell death (1)
  • gene (5)
  • human (3)
  • parkinson disease (3)
  • phenotypes (2)
  • protect cells (1)
  • rna (5)
  • yeast (2)
  • αSyn (7)
  • Sizes of these terms reflect their relevance to your search.

    The genome-wide perturbation of transcriptional networks with CRISPR-Cas technology has primarily involved systematic and targeted gene modulation. Here, we developed PRISM (Perturbing Regulatory Interactions by Synthetic Modulators), a screening platform that uses randomized CRISPR-Cas transcription factors (crisprTFs) to globally perturb transcriptional networks. By applying PRISM to a yeast model of Parkinson's disease (PD), we identified guide RNAs (gRNAs) that modulate transcriptional networks and protect cells from alpha-synuclein (αSyn) toxicity. One gRNA identified in this screen outperformed the most protective suppressors of αSyn toxicity reported previously, highlighting PRISM's ability to identify modulators of important phenotypes. Gene expression profiling revealed genes differentially modulated by this strong protective gRNA that rescued yeast from αSyn toxicity when overexpressed. Human homologs of top-ranked hits protected against αSyn-induced cell death in a human neuronal PD model. Thus, high-throughput and unbiased perturbation of transcriptional networks via randomized crisprTFs can reveal complex biological phenotypes and effective disease modulators. Copyright © 2017. Published by Elsevier Inc.


    Ying-Chou Chen, Fahim Farzadfard, Nava Gharaei, William C W Chen, Jicong Cao, Timothy K Lu. Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity. Molecular cell. 2017 Oct 05;68(1):247-257.e5

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 28985507

    View Full Text